Corrigendum to "From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides"
I tiakina i:
Hōputu: | Pukapuka |
---|---|
I whakaputaina: |
Elsevier,
2016-01-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_2865fb767dfa43a79a6adf30a4a91a53 | ||
042 | |a dc | ||
245 | 0 | 0 | |a Corrigendum to "From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides" |
260 | |b Elsevier, |c 2016-01-01T00:00:00Z. | ||
500 | |a 2162-2531 | ||
500 | |a 10.1038/mtna.2016.104 | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Molecular Therapy: Nucleic Acids, Vol 5, Iss C (2016) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2162253117300203 | |
787 | 0 | |n https://doaj.org/toc/2162-2531 | |
856 | 4 | 1 | |u https://doaj.org/article/2865fb767dfa43a79a6adf30a4a91a53 |z Connect to this object online. |